Associate Scientist, Biologics Formulation and Drug Product Development in San Francisco, CA

Save

compensation:

$100K - $150K

specialty:

Life Sciences

experience:

11 - 15 years

Job Description

Designs and develop preformulation, and conduct formulation screening and optimization studies for parenteral liquid and lyophilized biologic drug products to ensure stability and manufacturing feasibility for pre-clinical and clinical trials. This position contributes to and supports the company's research and product development efforts to create high value therapeutics to address unmet medical needs.

Responsible for design and development of new biologics drug formulations. Also responsible for formulation optimization with a view to establish the quality and stability of drug products. Works on complex problems in which analysis of situations or data requires an in-depth evaluation of various factors. Exercises judgment within broadly defined practices and policies in selecting methods, techniques and evaluation criteria for obtaining optimal results. Designs, executes, and interprets formulation studies based on defined deliverables, planning activities to meet project t

See More

Valid through: 2020-1-20

About Nektar Therapeutics

Nektar Therapeutics (Nektar) (NASDAQ: NKTR) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the worlds first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany. The company is engaged in developing a propriety pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The companys research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol (Movantik), a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc. In 2013, the company was assignment a patent which was developed by the company and other four co-inventors. The products of the company is served as a supplement to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability and other areas of drugs for the patients worldwide. As of March 2014, the company had an market capitalization of $1.7 billion with an enterprise value of $1.67 billion.
Total Jobs:
24
Average Pay:
$148,875
Total value of jobs:
$31,115,000
% Masters:
42%
Learn More About Nektar Therapeutics

More Jobs at Nektar Therapeutics

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Find similar Formulation Scientist jobs: